Literature DB >> 16424612

Mitochondrial DNA mutations in human neoplasia.

Anna M Czarnecka1, Pawel Golik, Ewa Bartnik.   

Abstract

Many models of tumour formation have been put forth so far. In general they involve mutations in at least three elements within the cell: oncogenes, tumour suppressors and regulators of telomere replication. Recently numerous mutations in mitochondria have been found in many tumours, whereas they were absent in normal tissues from the same individual. The presence of mutations, of course, does not prove that they play a causative role in development of neoplastic lesions and progression; however, the key role played by mitochondria in both apoptosis and generation of DNA-damaging reactive oxygen species might indicate that the observed mutations contribute to tumour development. Recent experiments with nude mice have proven that mtDNA mutations are indeed responsible for tumour growth and exacerbated ROS production. This review describes mtDNA mutations in main types of human neoplasia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16424612     DOI: 10.1007/BF03194602

Source DB:  PubMed          Journal:  J Appl Genet        ISSN: 1234-1983            Impact factor:   3.240


  80 in total

Review 1.  Mitochondria as the central control point of apoptosis.

Authors:  S Desagher; J C Martinou
Journal:  Trends Cell Biol       Date:  2000-09       Impact factor: 20.808

2.  Mitochondria: integrators in tumorigenesis?

Authors:  L H Augenlicht; B G Heerdt
Journal:  Nat Genet       Date:  2001-06       Impact factor: 38.330

3.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

4.  Mitochondrial genome instability and mtDNA depletion in human cancers.

Authors:  Hsin-Chen Lee; Pen-Hui Yin; Jin-Ching Lin; Cheng-Chung Wu; Chih-Yi Chen; Chew-Wun Wu; Chin-Wen Chi; Tseng-Nip Tam; Yau-Huei Wei
Journal:  Ann N Y Acad Sci       Date:  2005-05       Impact factor: 5.691

5.  Sequence and organization of the human mitochondrial genome.

Authors:  S Anderson; A T Bankier; B G Barrell; M H de Bruijn; A R Coulson; J Drouin; I C Eperon; D P Nierlich; B A Roe; F Sanger; P H Schreier; A J Smith; R Staden; I G Young
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962

Review 6.  Reactive oxygen species and mitochondrial diseases.

Authors:  I G Kirkinezos; C T Moraes
Journal:  Semin Cell Dev Biol       Date:  2001-12       Impact factor: 7.727

7.  Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer.

Authors:  Duan-Jun Tan; Ren-Kui Bai; Lee-Jun C Wong
Journal:  Cancer Res       Date:  2002-02-15       Impact factor: 12.701

8.  Breast cancer predisposing alleles in Poland.

Authors:  B Górski; C Cybulski; T Huzarski; T Byrski; J Gronwald; A Jakubowska; M Stawicka; S Gozdecka-Grodecka; M Szwiec; K Urbański; J Mituś; E Marczyk; J Dziuba; P Wandzel; D Surdyka; O Haus; H Janiszewska; T Debniak; A Tołoczko-Grabarek; K Medrek; B Masojć; M Mierzejewski; E Kowalska; S A Narod; J Lubiński
Journal:  Breast Cancer Res Treat       Date:  2005-07       Impact factor: 4.872

9.  Detection of mitochondrial DNA alterations in plasma of malignant melanoma patients.

Authors:  Hiroya Takeuchi; Akihide Fujimoto; Dave S B Hoon
Journal:  Ann N Y Acad Sci       Date:  2004-06       Impact factor: 5.691

10.  Differentiation of HT-29 human colonic adenocarcinoma cells correlates with increased expression of mitochondrial RNA: effects of trehalose on cell growth and maturation.

Authors:  X Lu; T Walker; J P MacManus; V L Seligy
Journal:  Cancer Res       Date:  1992-07-01       Impact factor: 12.701

View more
  26 in total

Review 1.  Genetic insights into OXPHOS defect and its role in cancer.

Authors:  Dhyan Chandra; Keshav K Singh
Journal:  Biochim Biophys Acta       Date:  2010-11-11

Review 2.  Mitochondria and cancer.

Authors:  Valdemar Máximo; Jorge Lima; Paula Soares; Manuel Sobrinho-Simões
Journal:  Virchows Arch       Date:  2009-04-03       Impact factor: 4.064

Review 3.  Regulation of metastasis; mitochondrial DNA mutations have appeared on stage.

Authors:  Kaori Ishikawa; Hirotake Imanishi; Keizo Takenaga; Jun-Ichi Hayashi
Journal:  J Bioenerg Biomembr       Date:  2012-12       Impact factor: 2.945

Review 4.  Opportunities and challenges for selected emerging technologies in cancer epidemiology: mitochondrial, epigenomic, metabolomic, and telomerase profiling.

Authors:  Mukesh Verma; Muin J Khoury; John P A Ioannidis
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-12-14       Impact factor: 4.254

Review 5.  Molecular oncology focus - is carcinogenesis a 'mitochondriopathy'?

Authors:  Anna M Czarnecka; Jerzy S Czarnecki; Wojciech Kukwa; Francesco Cappello; Anna Scińska; Andrzej Kukwa
Journal:  J Biomed Sci       Date:  2010-04-25       Impact factor: 8.410

6.  Mitochondrial genotype in vulvar carcinoma - cuckoo in the nest.

Authors:  Aleksandra Klemba; Magdalena Kowalewska; Wojciech Kukwa; Katarzyna Tonska; Aleksandra Szybinska; Malgorzata Mossakowska; Anna Scinska; Paweł Golik; Kamil Koper; Jakub Radziszewski; Andrzej Kukwa; Anna M Czarnecka; Ewa Bartnik
Journal:  J Biomed Sci       Date:  2010-09-08       Impact factor: 8.410

7.  Sequence variation in the mitochondrial gene cytochrome c oxidase subunit I and prostate cancer in African American men.

Authors:  Anna M Ray; Kimberly A Zuhlke; Albert M Levin; Julie A Douglas; Kathleen A Cooney; John A Petros
Journal:  Prostate       Date:  2009-06-15       Impact factor: 4.104

8.  Trading mtDNA uncovers its role in metastasis.

Authors:  Kaori Ishikawa; Jun-Ichi Hayashi
Journal:  Cell Adh Migr       Date:  2009-01-21       Impact factor: 3.405

Review 9.  Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy.

Authors:  Masuko Ushio-Fukai; Yoshimasa Nakamura
Journal:  Cancer Lett       Date:  2008-04-10       Impact factor: 8.679

10.  Common mitochondrial polymorphisms as risk factor for endometrial cancer.

Authors:  Anna M Czarnecka; Aleksandra Klemba; Andrzej Semczuk; Katarzyna Plak; Barbara Marzec; Tomasz Krawczyk; Barbara Kofler; Pawel Golik; Ewa Bartnik
Journal:  Int Arch Med       Date:  2009-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.